Full Length Research Paper
References
Brassard P, Bruneau J, Schwartzman K, Senecal M, Menzies D (2004). Yield of tuberculin screening among injection drug users. Int. J. Tuberc. Lung Dis. 8(8):988-93. |
||||
Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, Kanara N, Kimerling ME, Chheng P, Thai S, Sar B, Phanuphak N, Nguyen HD, Hoang TQ, Le HT, Varma JK (2010). An algorithm for tuberculosis screening and diagnosis in people with HIV.N Engl J Med. 362(8):707-716. Crossref |
||||
Cao G, Zhi Y (2006). An analysis of the screening results of tuberculosis in patients with HIV/AIDS. Disease Surveillance 21:400-402. | ||||
Centers for Disease Control and Prevention (2005). Screening HIV infected persons for tuberculosis-Cambodia, January 2004–February 2005. MMWR 54:1177-1180 Pubmed |
||||
Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C (2003). The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163(9):1009-1021. Crossref |
||||
Deiss RG, Rodwell TC, Garfein RS (2009). Tuberculosis and Illicit Drug Use: Review and Update. Clin. Infect. Dis. 48(1):72-82. Crossref |
||||
Dhungana GP, Ghimire P, Sharma S, Rijal BP (2008). Tuberculosis co-infection in HIV infected persons of Kathmandu. Nepal Med. Coll. J. 10(2):96-9. | ||||
Friedman H, Newton C, Klein TW (2003). Microbial infections, immunomodulation, and drugs of abuse. Clin. Microbiol. Rev. 16(2):209-19. Crossref |
||||
Gao L, Zhou F, Li X, Jin Q (2010). HIV/TB Co-Infection in Mainland China: A Meta-Analysis. PLoS One 5(5):e10736. Crossref |
||||
Getahun H, Gunneberg C, Granich R, Nunn P (2010). HIV infection–associated tuberculosis: the epidemiology and the response. Clin. Infect. Dis. 50(Suppl 3):201-207. Crossref |
||||
Ghimire P, Dhungana GR, Bam DS, Rijal BP (2004). Tuberculosis and HIV co-infection status in United Mission Hospital, Tansen, Western Nepal. SAARC J. Tuberc. Lung Dis. HIV/AIDS. 1:32-37. | ||||
Glynn JR (1998). Resurgence of tuberculosis and the impact of HIV infection. Br. Med. Bull. 54(3):579-93. Crossref |
||||
Grimes CZ, Hwang LY, Williams ML, Austin CM, Graviss EA (2007). Tuberculosis infection in drug users: interferon-gamma release assay performance. Int. J. Tuberc. Lung Dis. 11(11):1183-9. Pubmed |
||||
Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Anzar E, Miro JM, mallolas J, Zamora L, Gonzalez J (1993). A prospective study of the risk of tuberculosis among HIV infected patients. AIDS 7(10):1345-1349. Crossref |
||||
Gyawali N, Gurung R, Poudyal N, Amatya R, Shrestha R, Khanal LK, Timilsina S, Bhattacharya SK (2013). Tobacco and alcohol: the relation to pulmonary tuberculosis in household contacts. Nepal Med. Coll. J. 15(2):125-128. Pubmed |
||||
Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R (2011). Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the expert MTB/RIF Assay: A prospective Study. PLoS Med. 8(7):e1001067 Crossref |
||||
Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, Walker AT, Friedland GH (1989). A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320(9):545-50. Crossref |
||||
Sharma S, Dhungana GP, Pokhrel BM, Rijal BP (2010). Opportunistic infections in relation to CD4 level among HIV seropositive patients from central Nepal. Nepal Med. Coll. J. 12(1):1-4. Pubmed |
||||
Vermund SH, Yamamoto N (2007). Co-infection with human immunodeficiency virus and tuberculosis in Asia. Tuberculosis (Edinb) (87 Suppl)1:18-25. Crossref |
||||
Wang X, Liu F, Dong B (2007). Study on the detection rate of double infection among patients with AIDS and TB and its influencing factors. Mod. Prev. Med. 34:4457-4459. | ||||
Wei G, Moss J, Yuan CS (2003). Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated? Biochem Pharmacol. 65(11):1761-1766. Crossref |
||||
WHO Regional Strategic Plan on HIV/TB SEA/TB/261. SEA/AIDS/140 (2003). WHO regional office for South East Asia, October 2003. | ||||
World Health Organization (WHO) (2009). Global tuberculosis control: surveillance, planning, ï¬nancing. WHO report 2009, Geneva. | ||||
World Health Organization (WHO) (1998). Laboratory services in tuberculosis control. WHO/TB98.258. Geneva. | ||||
Yu L, Wang L, Tang Z, Huang S, Meng Z (2009). The diagnosis and investigation of active tuberculosis HIV/AIDS patients. Chin. J. Lab. Med. 32:377-382. |
Copyright © 2023 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0